jan m. Van Ree, PhD - Publications

Pharmacology University Medical Center Utrecht, Utrecht, Netherlands 
addiction, psychiatry

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Buisman-Pijlman FT, Gerrits MA, Van Ree JM. Increased opioid release in specific brain areas in animals exposed to prenatal morphine and emotional stress later in life. Neuroscience. 159: 405-13. PMID 19138727 DOI: 10.1016/J.Neuroscience.2008.11.010  0.724
2009 de Krom M, Staal WG, Ophoff RA, Hendriks J, Buitelaar J, Franke B, de Jonge MV, Bolton P, Collier D, Curran S, van Engeland H, van Ree JM. A common variant in DRD3 receptor is associated with autism spectrum disorder. Biological Psychiatry. 65: 625-30. PMID 19058789 DOI: 10.1016/J.Biopsych.2008.09.035  0.507
2008 Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 247-58. PMID 17460617 DOI: 10.1038/Sj.Npp.1301415  0.551
2008 Van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GAA, Van Wimersma Greidanus TB, Witter A, de Wied D. γ -Melanotropin and Brain Function Peptides of the Pars Intermedia. 263-276. DOI: 10.1002/9780470720646.ch15  0.655
2007 Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology. 193: 403-14. PMID 17476480 DOI: 10.1007/S00213-007-0792-1  0.54
2007 Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 289-97. PMID 17137758 DOI: 10.1016/J.Euroneuro.2006.10.003  0.516
2006 Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology. 185: 358-68. PMID 16521034 DOI: 10.1007/s00213-005-0298-7  0.531
2003 Terpstra J, Gispen-De Wied CC, Broekhoven MH, Frankhuijzen AC, Kahn RS, van Ree JM, Wiegant VM. Attenuated stress responsiveness in an animal model for neurodevelopmental psychopathological disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 249-56. PMID 12888184 DOI: 10.1016/S0924-977X(03)00010-5  0.341
2000 Van Ree JM, Niesink RJ, Van Wolfswinkel L, Ramsey NF, Kornet MM, Van Furth WR, Vanderschuren LJ, Gerrits MA, Van den Berg CL. Endogenous opioids and reward. European Journal of Pharmacology. 405: 89-101. PMID 11033317 DOI: 10.1016/S0014-2999(00)00544-6  0.455
2000 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology. 22: 293-302. PMID 10693157 DOI: 10.1016/S0893-133X(99)00118-9  0.344
1999 Van Berckel BNM, Evenblij CN, Van Loon BJAM, Maas MF, Van Der Geld MAM, Wynne HJ, Van Ree JM, Kahn RS. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind, parallel, placebo-controlled study Neuropsychopharmacology. 21: 203-210. PMID 10432468 DOI: 10.1016/S0893-133X(99)00014-7  0.318
1999 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study Biological Psychiatry. 45: 883-890. PMID 10202576 DOI: 10.1016/S0006-3223(98)00128-0  0.301
1999 Ramsey NF, Gerrits MA, Van Ree JM. Naltrexone affects cocaine self-administration in naïve rats through the ventral tegmental area rather than dopaminergic target regions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 93-9. PMID 10082233 DOI: 10.1016/S0924-977X(98)00009-1  0.437
1998 Reijmers LG, van Ree JM, Spruijt BM, Burbach JP, De Wied D. Vasopressin metabolites: a link between vasopressin and memory? Progress in Brain Research. 119: 523-35. PMID 10074810 DOI: 10.1016/S0079-6123(08)61591-5  0.449
1998 Popik P, van Ree JM. Neurohypophyseal peptides and social recognition in rats. Progress in Brain Research. 119: 415-36. PMID 10074804 DOI: 10.1016/S0079-6123(08)61585-X  0.554
1998 Van Berckel BNM, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, Van Ree JM, Kahn RS. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers Psychopharmacology. 138: 190-197. PMID 9718289 DOI: 10.1007/S002130050662  0.314
1998 Van Berckel BNM, Oranje B, Van Ree JM, Verbaten MN, Kahn RS. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects Psychopharmacology. 137: 271-281. PMID 9683005 DOI: 10.1007/S002130050620  0.348
1997 Vawter MP, De Wied D, Van Ree JM. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task. Neuropeptides. 31: 489-94. PMID 9413027  0.441
1997 Van Berckel BNM, Lipsch C, Timp S, Wied CGd, Wynne H, Van Ree JM, Kahn RS. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects Neuropsychopharmacology. 16: 317-324. PMID 9109102 DOI: 10.1016/S0893-133X(96)00196-0  0.334
1996 Kuzmin A, Semenova S, Ramsey NF, Zvartau EE, Van Ree JM. Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2+ channel modulators. European Journal of Pharmacology. 295: 19-25. PMID 8925870 DOI: 10.1016/0014-2999(95)00630-3  0.419
1996 Buitelaar JK, Dekker ME, van Ree JM, van Engeland H. A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 13-9. PMID 8866933 DOI: 10.1016/0924-977X(95)00049-U  0.567
1996 Popik P, Vetulani J, Van Ree JM. Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. European Journal of Pharmacology. 308: 113-6. PMID 8840121 DOI: 10.1016/0014-2999(96)00215-4  0.556
1996 Verbaten MN, Kemner C, Buitelaar JK, van Ree JM, van Beijsterveld CE, van Engeland H. Effects of ORG-2766 on brain event-related potentials of autistic children. Psychiatry Research. 63: 33-45. PMID 8832772 DOI: 10.1016/0165-1781(96)89319-X  0.524
1994 Gerrits MA, Ramsey NF, Wolterink G, van Ree JM. Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology. 114: 486-94. PMID 7855207 DOI: 10.1007/Bf02249340  0.462
1994 van Ree JM, Ramsey NF, Gerrits M. Endorphins, emotional stress and experimental cocaine addiction European Neuropsychopharmacology. 4: 208-210. DOI: 10.1016/0924-977X(94)90043-4  0.391
1993 Ramsey NF, Van Ree JM. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Research. 608: 216-22. PMID 8495356 DOI: 10.1016/0006-8993(93)91461-Z  0.44
1993 Popik P, Van Ree JM. Social transmission of flavored tea preferences: facilitation by a vasopressin analog and oxytocin. Behavioral and Neural Biology. 59: 63-8. PMID 8442734 DOI: 10.1016/0163-1047(93)91173-K  0.535
1993 Ramsey NF, Niesink RJ, Van Ree JM. Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats. Drug and Alcohol Dependence. 33: 41-51. PMID 8396529 DOI: 10.1016/0376-8716(93)90032-L  0.452
1993 Popik P, Vetulani J, van Ree JM. Social memory and neurohypophyseal hormones European Neuropsychopharmacology. 3: 200-201. DOI: 10.1016/0924-977X(93)90024-G  0.563
1992 Popik P, Vos PE, Van Ree JM. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behavioural Pharmacology. 3: 351-358. PMID 11224137 DOI: 10.1097/00008877-199208000-00011  0.539
1992 Popik P, Vetulani J, van Ree JM. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology. 106: 71-4. PMID 1738795 DOI: 10.1007/Bf02253591  0.52
1992 Popik P, Van Ree JM. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study. Life Sciences. 50: 567-72. PMID 1736027 DOI: 10.1016/0024-3205(92)90368-Y  0.561
1992 Ramsey NF, Van Ree JM. Reward and abuse of opiates. Pharmacology & Toxicology. 71: 81-94. PMID 1438034 DOI: 10.1111/J.1600-0773.1992.Tb00525.X  0.438
1992 Buitelaar JK, van Engeland H, de Kogel K, de Vries H, van Hooff J, van Ree J. The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 31: 1149-56. PMID 1331023 DOI: 10.1097/00004583-199211000-00026  0.645
1992 Buitelaar JK, van Engeland H, de Kogel KH, de Vries H, van Hooff JA, van Ree JM. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior. Biological Psychiatry. 31: 1119-29. PMID 1326339 DOI: 10.1016/0006-3223(92)90156-T  0.664
1992 Buitelaar JK, van Engeland H, de Kogel CH, de Vries H, van Hooff JA, van Ree JM. Deficits in social behavior in autism and their modification by a synthetic adrenocorticotrophic hormone (4-9) analog. Experientia. 48: 391-4. PMID 1316288 DOI: 10.1007/Bf01923438  0.66
1992 van Ree JM, Gerrits M, Ramsey NF. The involvement of endorphins and dopamine in experimental addiction European Neuropsychopharmacology. 2: 219-221. DOI: 10.1016/0924-977X(92)90074-I  0.455
1992 Hijman R, Jolles J, Verhoeven WMA, Van Ree JM, Elderson A, De Wied D. Desglycinamide-(Arg8)-vasopressin in five trials with memory-disturbed patients Human Psychopharmacology. 7: 7-23.  0.428
1991 Popik P, Wolterink G, De Brabander H, van Ree JM. Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats. Physiology & Behavior. 49: 1031-5. PMID 1896485 DOI: 10.1016/0031-9384(91)90327-K  0.549
1991 Wolterink G, van Ree JM, van Nispen JW, de Wied D. Structural modifications of the ACTH-(4-9) analog ORG 2766 yields peptides with high biological activity. Life Sciences. 48: 155-61. PMID 1847225 DOI: 10.1016/0024-3205(91)90409-5  0.471
1991 Popik P, Vetulani J, Bisaga A, van Ree JM. Recognition cue in the rat's social memory paradigm. Journal of Basic and Clinical Physiology and Pharmacology. 2: 315-27. PMID 1822146 DOI: 10.1515/Jbcpp.1991.2.4.315  0.535
1991 Ramsey NF, van Ree JM. Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacology, Biochemistry, and Behavior. 40: 807-10. PMID 1816567 DOI: 10.1016/0091-3057(91)90090-O  0.453
1991 Popik P, van Ree JM. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 555-60. PMID 1668316 DOI: 10.1016/0924-977X(91)90010-R  0.555
1990 Buitelaar JK, van Engeland H, van Ree JM, de Wied D. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children. Journal of Autism and Developmental Disorders. 20: 467-78. PMID 2177746 DOI: 10.1007/BF02216053  0.641
1990 Ramsey NF, van Ree JM. Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 55-61. PMID 2136215 DOI: 10.1016/0924-977X(90)90012-Y  0.444
1989 Kovács GL, Liu B, Burbach JP, Van Ree JM, De Wied D. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin. European Journal of Pharmacology. 161: 27-35. PMID 2721547 DOI: 10.1016/0014-2999(89)90176-3  0.588
1989 de Wied D, van Ree JM. Neuropeptides: animal behaviour and human psychopathology. European Archives of Psychiatry and Neurological Sciences. 238: 323-31. PMID 2670577 DOI: 10.1007/BF00449813  0.492
1987 de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. The Journal of Pharmacology and Experimental Therapeutics. 241: 268-74. PMID 3572787  0.58
1987 Laczi F, László FA, Kovács GL, Telegdy G, Szász A, Szilárd J, van Ree JM, de Wied D. Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinologica. 115: 392-8. PMID 3303787 DOI: 10.1530/Acta.0.1150392  0.511
1987 De Wied D, Van Ree JM. Non-opiate effects of neuropeptides derived from beta-endorphin. Polish Journal of Pharmacology and Pharmacy. 39: 623-32. PMID 2976164  0.45
1987 van Ree JM, Verhoeven WM, de Wied D. Animal and clinical research on neuropeptides and schizophrenia. Progress in Brain Research. 72: 249-67. PMID 2441432 DOI: 10.1016/S0079-6123(08)60213-7  0.576
1986 Drago F, Van Ree JM, De Wied D. Desenkephalin-gamma-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine. European Journal of Pharmacology. 128: 205-12. PMID 3792442 DOI: 10.1016/0014-2999(86)90767-3  0.467
1986 Fekete M, Van Ree JM, De Wied D. The ACTH-(4-9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats. Peptides. 7: 563-8. PMID 3020524  0.488
1986 Drago F, Bohus B, Bitetti R, Scapagnini U, van Ree JM, de Wied D. Intracerebroventricular injection of anti-prolactin serum suppresses excessive grooming of pituitary homografted rats. Behavioral and Neural Biology. 46: 99-105. PMID 3015122 DOI: 10.1016/S0163-1047(86)90938-6  0.451
1986 van Ree JM, Verhoeven WM, Claas FH, de Wied D. Antipsychotic action of gamma-type endorphins: animal and human studies. Progress in Brain Research. 65: 221-35. PMID 2431435 DOI: 10.1016/S0079-6123(08)60653-6  0.589
1986 Claas FH, van Ree JM, Verhoeven WM, van der Poel JJ, Verduyn W, de Wied D, van Rood JJ. The interaction between gamma-type endorphins and HLA class I antigens. Human Immunology. 15: 347-56. PMID 2422143 DOI: 10.1016/0198-8859(86)90011-X  0.583
1985 Fekete M, van Ree JM, Niesink RJ, de Wied D. Disrupting circadian rhythms in rats induces retrograde amnesia. Physiology & Behavior. 34: 883-7. PMID 4059376 DOI: 10.1016/0031-9384(85)90008-3  0.437
1985 Van Ree JM, Hijman R, Jolles J, De Wied D. Vasopressin and related peptides: animal and human studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 551-9. PMID 3911283 DOI: 10.1016/0278-5846(85)90016-8  0.632
1985 van Ree JM, de Wied D. Behavioral effects of non-opioid fragments of beta-endorphin. Progress in Clinical and Biological Research. 192: 277-84. PMID 2934744  0.459
1985 Van Ree JM, Verhoeven WM, De Wied D. Gamma-type endorphins: neurolepticum-like and antipsychotic action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 561-7. PMID 2418467 DOI: 10.1016/0278-5846(85)90017-X  0.629
1984 de Wied D, Gaffori O, van Ree JM, de Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature. 308: 276-8. PMID 6322010  0.479
1984 Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4  0.645
1984 van Ree JM, Verhoeven WM, Brouwer GJ, de Wied D. Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report. Neuropsychobiology. 12: 4-8. PMID 6151145 DOI: 10.1159/000118101  0.643
1984 De Wied D, Gaffori O, Van Ree JM, De Jong W. Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmacology, Biochemistry, and Behavior. 21: 393-400. PMID 6093152  0.464
1983 Laczi F, van Ree JM, Wagner A, Valkusz Z, Járdánházy T, Kovács GL, Telegdy G, Szilárd J, László FA, de Wied D. Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects. Acta Endocrinologica. 102: 205-12. PMID 6829260 DOI: 10.1530/Acta.0.1020205  0.549
1983 van Wimersma Greidanus TB, van Ree JM, de Wied D. Vasopressin and memory. Pharmacology & Therapeutics. 20: 437-58. PMID 6351117 DOI: 10.1016/0163-7258(83)90036-0  0.621
1983 Fekete M, Drago F, Van Ree JM, Bohus B, Wiegant VM, De Wied D. Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766). Life Sciences. 32: 2193-204. PMID 6302425 DOI: 10.1016/0024-3205(83)90417-4  0.474
1983 Van Ree JM, Gaffori O, De Wied D. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. European Journal of Pharmacology. 93: 63-78. PMID 6138272 DOI: 10.1016/0014-2999(83)90031-6  0.485
1983 Serra G, Van Ree JM, de Wied D. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response. The Journal of Pharmacy and Pharmacology. 35: 255-7. PMID 6133940  0.383
1982 de Jongh BM, Verhoeven WM, van Ree JM, de Wied D, van Rood JJ. Hla, and the response to treatment with gamma-type endorphins in schizophrenia. Journal of Immunogenetics. 9: 381-8. PMID 6186747 DOI: 10.1111/j.1744-313X.1982.tb00999.x  0.593
1982 Nijkamp FP, van Ree JM, Nijssen JG, Versluis M, de Wied D. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 213-7. PMID 6185856 DOI: 10.1007/BF00505488  0.408
Show low-probability matches.